Skip to main content
. 2014 Feb 18;20:268–273. doi: 10.12659/MSM.890052

Table 2.

Comparison of baseline characteristics and pharmacological agents according to pace modes.

Variable Overall (N=104)
n, %
VVI (N=21)
n, %
Non-VVI (N=83)
n, %
p-Value
Age (mean, SD) 68.15 (17.63) 67 (23.34) 68.45 (16.03) 0.791
BMI (mean, SD) 29 (5.65) 27.94 (6.08) 29.26 (5.54) 0.343
Creatinine (mean, SD) 1.02 (0.4) 1.001 (0.41) 1.03 (0.403) 0.763
LA Size (mean, SD) 45.85 (8.20) 51.1 (10.4) 44.5 (6.98) 0.013
Gender (male) 54 (51.92) 10 (47.62) 44 (53.01) 0.807
Ethnicity (Hispanic) 68 (65.38) 15 (71.43) 53 (63.86) 0.831
Diabetes mellitus (yes) 28 (26.92) 7 (33.33) 21 (25.3) 0.582
Hypertension (yes) 76 (73.08) 14 (16.67) 62 (74.70) 0.582
Dyslipidemia (yes) 55 (52.88) 10 (47.62) 45 (54.22) 0.631
Coronary artery disease (yes) 26 (25.00) 7 (33.33) 19 (22.89) 0.398
Congestive heart failure (yes) 31 (29.81) 6 (28.57) 25 (30.12) 1.000
History of smoking (yes) 47 (45.19) 12 (57.14) 35 (42.17) 0.231
History of alcohol use (yes) 37 (35.58) 10 (47.62) 27 (32.53) 0.212
History of illegal drugs (yes) 10 (9.62) 3 (14.29) 7 (8.43) 0.418
ACE-inhibitor (yes) 58 (55.77) 10 (47.62) 48 (57.84) 0.465
ARB-inhibitor(yes) 8 (7.69) 1 (4.76) 7 (8.43) 1.000
Statin(yes) 52 (50.00) 9 (42.86) 43 (51.81) 0.626
Diuretics (yes) 39 (37.50) 9 (42.86) 30 (36.14) 0.619
Antiarrhythmics (yes) 23 (22.12) 5 (23.81) 18 (21.69) 0.777